Galectin Therapeutics Inc (NASDAQ:GALT)

3.54
Delayed Data
As of Mar 27
 -0.01 / -0.28%
Today’s Change
3.00
Today|||52-Week Range
17.14
+2.02%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +351.98% increase from the last price of 3.54.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.27
Sales
--
Reporting Date
May 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -50.00%
 
 
 
 
 
 
Growthannually -14.10%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account